A surgeon on social media says the FDA has received two death reports involving black-market retatrutide. No official FDA statement is linked.
Recap by typeshit. Post by @realdrbae on Instagram.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
One writer shares her own unexpected pregnancy while taking the tirzepatide shot, and says many others have been through the same thing.
Researchers looked at U.S. adults with type 2 diabetes starting a GLP-1 and estimate a small added risk of sudden vision loss that is often permanent.
Cases climbed from 5 a month to 217 by September 2026, NSW Health figures show. Black-market retatrutide was involved in 71% of the visits.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Loading…